Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-25-003911
Filing Date
2025-06-16
Accepted
2025-06-16 16:18:57
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5827
  Complete submission text file 0001171843-25-003911.txt   7257
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address
Frank Steven (Reporting) CIK: 0001583886 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 251050326